The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.

G. H. McCracken, U. B. Schaad

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
JournalReviews of Infectious Diseases
Volume4 Suppl
StatePublished - Nov 1982

Fingerprint

Cephamycins
Moxalactam
Escherichia coli Infections
Cephalosporins
Meningitis
Rabbits
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

@article{dbcf0e74b3b047c4beb8f1eef7395ea5,
title = "The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.",
author = "McCracken, {G. H.} and Schaad, {U. B.}",
year = "1982",
month = "11",
language = "English (US)",
volume = "4 Suppl",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - The pharmacologic basis for moxalactam therapy for gram-negative enteric bacillary meningitis of infancy.

AU - McCracken, G. H.

AU - Schaad, U. B.

PY - 1982/11

Y1 - 1982/11

UR - http://www.scopus.com/inward/record.url?scp=0020210659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020210659&partnerID=8YFLogxK

M3 - Article

C2 - 6218571

AN - SCOPUS:0020210659

VL - 4 Suppl

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -